#Sclerodermas

شاهد فيديو ريلز عن Sclerodermas من أشخاص حول العالم.

شاهد بشكل مجهول دون تسجيل الدخول.

ريلز رائجة

(4)
#Sclerodermas Reel by @sclerodermajourney_chelby - Thanking my family for participating in Rare Disease Day yesterday. This was lovely to see @rarediseasedayofficial #showyourstripes #sclerodermaawaren
151
SC
@sclerodermajourney_chelby
Thanking my family for participating in Rare Disease Day yesterday. This was lovely to see @rarediseasedayofficial #showyourstripes #sclerodermaawareness #sclerodermawarrior #helpfindacureforscleroderma
#Sclerodermas Reel by @themoexperience25 - #RareDiseaseDay #raredc2026 #themoexperience25 #RareButNotInvisible #sclerodermaawareness #EquityForRare
140
TH
@themoexperience25
#RareDiseaseDay #raredc2026 #themoexperience25 #RareButNotInvisible #sclerodermaawareness #EquityForRare
#Sclerodermas Reel by @road_back_foundation (verified account) - Is scleroderma a treatable infection?
The data from the Road Back Foundation patient community says this question must be asked.
In a review of 304 in
150
RO
@road_back_foundation
Is scleroderma a treatable infection? The data from the Road Back Foundation patient community says this question must be asked. In a review of 304 individuals diagnosed with systemic scleroderma who shared their outcomes on the RBF Patient Community Discussion Forum: • 221 patients (73%) reported remission • 82 patients (27%) reported noticeable improvement • Only 2 patients (<1%) reported no improvement Even more striking — among 97 scleroderma patients who reported being tested for Lyme disease: • 71 (73%) tested positive • 24 (25%) tested negative • Lyme testing is known to produce high false-negative rates These outcomes were reported by patients using antibiotic protocol therapy, a treatment approach first advanced by rheumatologist Dr. Thomas McPherson Brown and supported by decades of clinical experience. Yet today, most scleroderma patients are still placed on long-term immune-suppressing drugs — often without being screened for infectious triggers that may be driving the disease process. Before suppressing the immune system, shouldn’t we rule out infection? At Road Back Foundation, we believe: ✔️ Scleroderma should be evaluated as a potentially infection-driven illness ✔️ Patients deserve comprehensive screening before irreversible treatment decisions ✔️ First, do no harm must remain the guiding principle of care 📌 These data reflect real-world patient-reported outcomes from one of the largest scleroderma-focused communities in the world. 🔗 Learn more at RoadBack.org #Scleroderma #SystemicSclerosis #LymeDisease #LymeArthritis #InfectiousAutoimmunity #AntibioticProtocol #APTherapy #AutoimmuneDisease #RareDisease #PatientReportedOutcomes #MedicalFreedom #InformedConsent #ChronicIllness #Misdiagnosis #FunctionalMedicine #IntegrativeMedicine #RoadBackFoundation #FirstDoNoHarm
#Sclerodermas Reel by @sclerodermacan - Today on Rare Disease Day, we're talking about something that doesn't always get the spotlight - policy.
Policy might sound technical or political. Bu
728
SC
@sclerodermacan
Today on Rare Disease Day, we’re talking about something that doesn’t always get the spotlight — policy. Policy might sound technical or political. But for people living with rare diseases, policy is personal. It determines: • How long it takes to get diagnosed • Whether treatments are covered • If life-saving medications are affordable • How quickly new therapies are approved • Whether patients can access specialists close to home • How research is funded For rare diseases like systemic sclerosis, delays and gaps in the system don’t just create inconvenience — they compound disease burden. Diagnostic delays, limited drug access, and inconsistent coverage across provinces are not medical problems alone. They are policy problems. Good policy means: ✔ Faster diagnoses ✔ Fair and equitable drug access ✔ Investment in research ✔ Support for caregivers ✔ A stronger, more responsive health system On Rare Disease Day, we honour the strength of our community — and we reaffirm that advocacy matters. Because when policy improves, lives improve. #RareDiseaseDay #PolicyMatters #HealthEquity #RareDiseaseAdvocacy

✨ دليل اكتشاف #Sclerodermas

يستضيف انستقرام thousands of منشور تحت #Sclerodermas، مما يخلق واحدة من أكثر النظم البصرية حيوية على المنصة.

#Sclerodermas هو أحد أكثر الترندات تفاعلاً على انستقرام حالياً. مع أكثر من thousands of منشور في هذه الفئة، يتصدر صناع المحتوى مثل @sclerodermacan, @sclerodermajourney_chelby and @road_back_foundation بمحتواهم الفيروسي. تصفح هذه الفيديوهات الشائعة بشكل مجهول على Pictame.

ما هو الترند في #Sclerodermas؟ أكثر مقاطع فيديو Reels مشاهدة والمحتوى الفيروسي معروضة أعلاه.

الفئات الشعبية

📹 اتجاهات الفيديو: اكتشف أحدث Reels والفيديوهات الفيروسية

📈 استراتيجية الهاشتاق: استكشف خيارات الهاشتاق الرائجة لمحتواك

🌟 صناع المحتوى المميزون: @sclerodermacan, @sclerodermajourney_chelby, @road_back_foundation وآخرون يقودون المجتمع

الأسئلة الشائعة حول #Sclerodermas

مع Pictame، يمكنك تصفح جميع ريلز وفيديوهات #Sclerodermas دون تسجيل الدخول إلى انستقرام. لا حساب مطلوب ونشاطك يبقى خاصاً.

تحليل الأداء

تحليل 4 ريلز

🔥 منافسة عالية

💡 المنشورات الأفضل تحصل على متوسط 439.5 مشاهدة (1.5× فوق المتوسط)

ركز على أوقات الذروة (11-13، 19-21) والصيغ الرائجة

نصائح إنشاء المحتوى والاستراتيجية

🔥 #Sclerodermas يظهر نمو مستقر - انشر باستمرار لبناء الحضور

📹 مقاطع الفيديو العمودية عالية الجودة (9:16) تعمل بشكل أفضل لـ #Sclerodermas - استخدم إضاءة جيدة وصوت واضح

✍️ التعليقات التفصيلية مع القصة تعمل بشكل جيد - متوسط الطول 809 حرف

✨ العديد من المبدعين الموثقين نشطون (25%) - ادرس أسلوب محتواهم

عمليات البحث الشائعة المتعلقة بـ #Sclerodermas

🎬لمحبي الفيديو

Sclerodermas Reelsمشاهدة فيديوهات Sclerodermas

📈للباحثين عن الاستراتيجية

Sclerodermas هاشتاقات رائجةأفضل Sclerodermas هاشتاقات

🌟استكشف المزيد

استكشف Sclerodermas#linear scleroderma awareness month#morphea scleroderma#scleroderma and autoimmune diseases#scleroderma awareness month#scleroderma treatment options 2026#localized scleroderma#scleroderma support groups online#scleroderma symptoms in women